71 related articles for article (PubMed ID: 2578429)
1. Studies on cytotoxicity generated in human mixed lymphocyte culture. IV. Interleukin 2 alone or from mixed lymphocyte culture yields natural killer-like cytotoxic cells distinct from allospecific cytotoxic T lymphocytes.
Shau H; Gray JD; Golub SH
Cancer Immunol Immunother; 1988; 27(3):255-60. PubMed ID: 2972366
[TBL] [Abstract][Full Text] [Related]
2. Defective T helper activity in the spleen of BALB/c mice immune to a syngeneic fibrosarcoma.
Grazioli L; Sensi M; Parmiani G
Cancer Immunol Immunother; 1987; 24(3):237-43. PubMed ID: 2954636
[TBL] [Abstract][Full Text] [Related]
3. Induction of preferential cytotoxicity against allogeneic mouse lymphoma cells: in vitro and in vivo studies.
Leshem B; Dorfman Y; Kedar E
Cancer Immunol Immunother; 1999 Jul; 48(4):179-88. PubMed ID: 10431687
[TBL] [Abstract][Full Text] [Related]
4. Tumour-reactive lymphocytes stimulated in mixed lymphocyte and tumour culture. Clonal analysis of effector cells in cytotoxic and proliferative assays.
Vose BM; White W
Cancer Immunol Immunother; 1983; 15(3):227-36. PubMed ID: 6225511
[TBL] [Abstract][Full Text] [Related]
5. Proliferative and cytotoxic responses of human peripheral blood lymphocytes to autologous malignant effusions. An analysis at the clonal level.
Roberts TE; Shipton U; Moore M
Cancer Immunol Immunother; 1986; 22(2):107-13. PubMed ID: 2941144
[TBL] [Abstract][Full Text] [Related]
6. In vitro elicitation of cytotoxic response against a nonimmunogenic murine tumor by allosensitization.
Leshem B; Gotsman B; Kedar E
Cancer Immunol Immunother; 1984; 17(2):117-23. PubMed ID: 6235909
[TBL] [Abstract][Full Text] [Related]
7. Regression mechanisms of mouse fibrosarcoma cells after in vitro exposure to quercetin: diminution of tumorigenicity with a corresponding decrease in the production of prostaglandin E2.
Okada F; Hosokawa M; Hasegawa J; Ishikawa M; Chiba I; Nakamura Y; Kobayashi H
Cancer Immunol Immunother; 1990; 31(6):358-64. PubMed ID: 2386981
[TBL] [Abstract][Full Text] [Related]
8. Adriamycin-induced activation of NK activity may initially involve LAF production.
Cohen SA; Salazar D; Wicher J
Cancer Immunol Immunother; 1983; 15(3):188-93. PubMed ID: 6193867
[TBL] [Abstract][Full Text] [Related]
9. Complementary activation of peripheral natural killer cell immunity in nasopharyngeal carcinoma.
Zheng Y; Cao KY; Ng SP; Chua DT; Sham JS; Kwong DL; Ng MH; Lu L; Zheng BJ
Cancer Sci; 2006 Sep; 97(9):912-9. PubMed ID: 16805822
[TBL] [Abstract][Full Text] [Related]
10. The use of cytotoxic T cells in the regulation of tumour growth in syngeneic mice.
Kwong L; Kilburn DG; Teh HS
Cancer Immunol Immunother; 1984; 17(3):205-12. PubMed ID: 6332673
[TBL] [Abstract][Full Text] [Related]
11. Human anti-lymphoma responses generated in vitro and in vivo following sensitization with allogeneic leukocytes.
Zarling JM; Kay NE; Grant B; Yasukawa M; Bach FH
Cancer Immunol Immunother; 1983; 15(3):237-9. PubMed ID: 6604571
[TBL] [Abstract][Full Text] [Related]
12. Immune recognition of tumor cells in mice infected with Pichinde virus.
Molomut N; Padnos M; Papperman TW; Pevear DC; Pfau CJ
Cancer Immunol Immunother; 1984; 17(1):56-61. PubMed ID: 6203637
[TBL] [Abstract][Full Text] [Related]
13. Recognition of Apoptotic Cells by Viruses and Cytolytic Lymphocytes: Target Selection in the Fog of War.
Schwartz D; Iyengar S
Viral Immunol; 2020 Apr; 33(3):188-196. PubMed ID: 32286181
[TBL] [Abstract][Full Text] [Related]
14. Editorial: Mechanisms of lymphocyte mediated cytotoxicity in health and disease.
Baldari CT; Valitutti S; Dustin ML
Front Immunol; 2023; 14():1226870. PubMed ID: 37325629
[No Abstract] [Full Text] [Related]
15. Interaction of lymphokine-activated killer cells with susceptible targets does not induce second messenger generation and cytolytic granule exocytosis.
Zanovello P; Rosato A; Bronte V; Cerundolo V; Treves S; Di Virgilio F; Pozzan T; Biasi G; Collavo D
J Exp Med; 1989 Sep; 170(3):665-77. PubMed ID: 2769181
[TBL] [Abstract][Full Text] [Related]
16. Suppressor cells induced by influenza virus inhibit interleukin-2 production in mice.
Del Gobbo V; Villani N; Marini S; Balestra E; Caliò R
Immunology; 1990 Mar; 69(3):454-9. PubMed ID: 2138128
[TBL] [Abstract][Full Text] [Related]
17. Reversibility of lymphokine-induced NK-like activity in virus-specific cytotoxic T-lymphocyte clones.
Ronchese F; Collavo D; Zanovello P; Cerundolo V; Biasi G
Immunology; 1985 Feb; 54(2):265-74. PubMed ID: 2578429
[TBL] [Abstract][Full Text] [Related]
18. Functional activity in vivo of effector T cell populations. III. Protection against Moloney murine sarcoma virus (M-MSV)-induced tumors in T cell deficient mice by the adoptive transfer of a M-MSV-specific cytolytic T lymphocyte clone.
Cerundolo V; Lahaye T; Horvath C; Zanovello P; Collavo D; Engers HD
Eur J Immunol; 1987 Feb; 17(2):173-8. PubMed ID: 3030766
[TBL] [Abstract][Full Text] [Related]
19. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
Sensi M; Orosz CG; Bach FH
J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
